NAMSA Has Deep Preclinical and Clinical Expertise in Numerous Therapeutic Areas

Experience Matters

At NAMSA, we believe that relevant therapeutic experience is one of the main components of successful scientific, regulatory, and commercialization outcomes. We take great care to support your specific goals by appointing a project team comprised of experts with relevant product experience…a team that understands the nuances of your particular medical device, providing best practices and proven strategies to help you achieve desired outcomes.

Device Category Experience

Last year, NAMSA conducted 1,650+ preclinical studies and 270+ clinical research projects. We have established a reputation for our extensive knowledge of medium/high-risk devices in the cardiovascular, neurology, orthopedics, and wound care segments. However, our expertise does not stop there as seen below. Learn more about our experience in the following areas.


Meet NAMSA’s Experts

Explore the depth of our team’s expertise in preclinical and clinical services.

Meet All Our Experts
  • Alfred Dibao-Dina, PhD

    Biological Safety Scientist
    View Bio
  • Megan A. Hahn, PhD, DABT

    Meghan Hahn
    Senior Toxicologist
    View Bio
  • Jack Risdahl, DVM, PhD

    Jack Risdahl
    Principal Strategy Consultant, Preclinical
    View Bio
  • Corie Diaz, BA, MBA

    Corie Diaz
    Global Director, Clinical Operations
    View Bio
  • Michael A. Jorgenson, BS

    Principal Interventionalist
    View Bio
  • Sara Finocchietti, MEng, PhD

    Senior Strategy Consultant, Clinical
    View Bio

Know Now with NAMSA

Join 40,000+ medical device professionals who stay up to date with insights from NAMSA subject matter experts. Sent 2x/month.